Creative Planning - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 231 filers reported holding MYRIAD GENETICS INC in Q4 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
Creative Planning ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q2 2024$221,534
-9.2%
9,057
+1.2%
0.00%
-100.0%
Q4 2019$244,000
+3.4%
8,951
+8.5%
0.00%0.0%
Q3 2019$236,000
-5.2%
8,251
+10.0%
0.00%0.0%
Q1 2019$249,000
+7.8%
7,500
-5.5%
0.00%0.0%
Q4 2018$231,000
-13.2%
7,933
+37.2%
0.00%0.0%
Q3 2018$266,000
+12.2%
5,783
-16.1%
0.00%0.0%
Q4 2017$237,000
-9.9%
6,894
-5.3%
0.00%0.0%
Q3 2017$263,000
+64.4%
7,283
+17.5%
0.00%0.0%
Q2 2017$160,000
+31.1%
6,200
-2.7%
0.00%0.0%
Q1 2017$122,000
+28.4%
6,371
+11.8%
0.00%0.0%
Q4 2016$95,000
-18.8%
5,7000.0%0.00%0.0%
Q3 2016$117,000
-32.8%
5,7000.0%0.00%0.0%
Q2 2016$174,000
-18.3%
5,7000.0%0.00%
-50.0%
Q1 2016$213,000
-16.5%
5,700
-3.4%
0.00%0.0%
Q4 2015$255,000
+13.3%
5,900
-1.7%
0.00%0.0%
Q3 2015$225,000
+1.8%
6,000
-4.0%
0.00%0.0%
Q1 2015$221,000
-25.3%
6,250
-41.5%
0.00%
-33.3%
Q4 2014$296,000
+29.3%
10,690
+36.7%
0.00%0.0%
Q3 2014$229,000
-29.8%
7,819
-22.9%
0.00%
-25.0%
Q2 2014$326,000
+15.6%
10,140
+23.1%
0.00%0.0%
Q1 2014$282,000
+158.7%
8,240
+58.5%
0.00%
+100.0%
Q4 2013$109,000
-10.7%
5,2000.0%0.00%0.0%
Q3 2013$122,000
-17.0%
5,200
-5.1%
0.00%
-33.3%
Q2 2013$147,0005,4800.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Tieton Capital Management, LLC 122,428$3,618,0003.32%
Sensato Investors LLC 553,505$16,356,0002.54%
Camber Capital Management LP 1,500,000$44,325,0002.18%
S&T BANK/PA 387,084$11,439,0002.04%
Taylor Frigon Capital Management LLC 46,989$1,389,0001.08%
AIMZ Investment Advisors, LLC 43,785$1,294,0000.94%
Matarin Capital Management, LLC 398,828$11,785,367,0000.88%
Summit Street Capital Management, LLC 30,097$889,0000.88%
DISCIPLINED GROWTH INVESTORS INC /MN 1,321,171$39,041,0000.77%
Millrace Asset Group, Inc. 45,544$1,346,0000.65%
View complete list of MYRIAD GENETICS INC shareholders